Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 938 JPY 1.3% Market Closed
Market Cap: 26.3B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharma Foods International Co Ltd
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Interest Income Expense
-ÂĄ114m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Interest Income Expense
-ÂĄ605.6m
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Interest Income Expense
-ÂĄ550m
CAGR 3-Years
-30%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
Takara Bio Inc
TSE:4974
Interest Income Expense
ÂĄ169m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
3%
S
StemRIM Inc
TSE:4599
Interest Income Expense
-ÂĄ183k
CAGR 3-Years
0%
CAGR 5-Years
8%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Interest Income Expense
ÂĄ1.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
26.3B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 64%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Interest Income Expense?
Interest Income Expense
-114m JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Interest Income Expense amounts to -114m JPY.

What is Pharma Foods International Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
-3%

Over the last year, the Interest Income Expense growth was -3%.

Back to Top